Vaccination against hepatitis B virus in Spain: a cost-effectiveness analysis (Q45759566)

15 December 2017

title

Vaccination against hepatitis B virus in Spain: a cost-effectiveness analysis (English)

1 reference

15 December 2017

1 reference

7

1 reference

15 December 2017

author name string

Garuz R

1

1 reference

15 December 2017

Torrea JL

2

1 reference

15 December 2017

Arnal JM

3

1 reference

15 December 2017

Forcen T

4

1 reference

15 December 2017

Trinxet C

5

1 reference

15 December 2017

Anton F

6

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

15

1 reference

15 December 2017

issue

15

1 reference

15 December 2017

page(s)

1652-1660

1 reference

15 December 2017

Prevalence of hepatitis B markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

Persistence of antibodies after immunization with a recombinant yeast-derived hepatitis B vaccine following two different schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

Efficacy of hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

Low-dose hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

Cost-Benefit Analysis of Hepatitis-B Vaccination: A Computerized Decision Model for Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

Cost-effectiveness analysis of hepatitis B vaccination strategies in Catalonia, Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

The use of mathematical models in the epidemiological study of infectious diseases and in the design of mass immunization programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

[The efficacy of universal vaccination against the hepatitis B virus. Simulation with a mathematical model].

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900083-2

7 January 2021

10.1016/S0264-410X(97)00083-2

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

9364696

1 reference

15 December 2017